{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:40:17Z","timestamp":1739968817198,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1124\/mol.105.020529","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T01:33:30Z","timestamp":1134610410000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel Targeting of Cyclooxygenase-2 (COX-2) Pre-mRNA Using Antisense Morpholino Oligonucleotides Directed to the 3\u2032 Acceptor and 5\u2032 Donor Splice Sites of Exon 4: Suppression of COX-2 Activity in Human Amnion-Derived WISH and Myometrial Cells"],"prefix":"10.1016","volume":"69","author":[{"given":"Alison J.","family":"Tyson-Capper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Nicholas","family":"Europe-Finner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.020529_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/gene.1060","article-title":"A zebrafish vasa morphant abolishes vasa protein but does not affect the establishment of the germline","volume":"30","author":"Braat","year":"2001","journal-title":"Genesis"},{"key":"10.1124\/mol.105.020529_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/jme.0.0160107","article-title":"Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids","volume":"16","author":"Chakraborty","year":"1996","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/mol.105.020529_bib3","first-page":"514","article-title":"Endocrine and paracrine regulation of birth at term and preterm","volume":"21","author":"Challis","year":"2000","journal-title":"Endocrine Rev"},{"key":"10.1124\/mol.105.020529_bib4","first-page":"F97","article-title":"Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids","volume":"263","author":"Coyne","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.020529_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J"},{"key":"10.1124\/mol.105.020529_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/gene.1062","article-title":"A morpholino phenocopy of the colourless mutant","volume":"30","author":"Dutton","year":"2001","journal-title":"Genesis"},{"key":"10.1124\/mol.105.020529_bib7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0002-9440(10)63567-5","article-title":"A new model for inflammation induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4","volume":"163","author":"Elovitz","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.105.020529_bib8","doi-asserted-by":"crossref","first-page":"36193","DOI":"10.1074\/jbc.274.51.36193","article-title":"Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides","volume":"274","author":"Friedman","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020529_bib9","doi-asserted-by":"crossref","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","article-title":"The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes","volume":"265","author":"Fu","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020529_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1471-0528.2005.00539.x","article-title":"TOCOX-a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk","volume":"112","author":"Groom","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1124\/mol.105.020529_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","article-title":"Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2","volume":"1","author":"Gupta","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.105.020529_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/dbio.2001.0565","article-title":"Morpholino oligos: making sense of antisense","volume":"243","author":"Heasman","year":"2002","journal-title":"Dev Biol"},{"key":"10.1124\/mol.105.020529_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/oli.1.1996.6.267","article-title":"Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation","volume":"6","author":"Hudziak","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1124\/mol.105.020529_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/nar\/gkh187","article-title":"Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA","volume":"32","author":"Ittig","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.105.020529_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0026-895X(24)12074-3","article-title":"Deletion of individual exons and induction of soluble interleukin-5 receptor-a chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing","volume":"58","author":"Karras","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.020529_bib16","first-page":"G327","article-title":"Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-\u03f5 dependent","volume":"283","author":"Kaur","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.105.020529_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase 2-deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"10.1124\/mol.105.020529_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1521-6934(03)00047-6","article-title":"Prostaglandin inhibitors in preterm labour","volume":"17","author":"Loudon","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1124\/mol.105.020529_bib19","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1073\/pnas.0401069101","article-title":"Endometrial calbindins are critical for embryo implantation: evidence from in vivo use of morpholino antisense oligonucleotides","volume":"101","author":"Luu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020529_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.plefa.2003.04.004","article-title":"Expression, localization and function of prostaglandin receptors in myometrium","volume":"70","author":"Myatt","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/mol.105.020529_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jsgi.2005.06.004","article-title":"The promise of prostaglandins: have they fulfilled their potential as therapeutic targets for the delay of preterm birth?","volume":"12","author":"Olson","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1124\/mol.105.020529_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1568006054553381","article-title":"Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?","volume":"5","author":"Paramo","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"10.1124\/mol.105.020529_bib23","first-page":"1928","article-title":"Spatio-temporal expression of the trans acting splicing factors SF2\/ASF and hnRNPA1\/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo","volume":"85","author":"Pollard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/mol.105.020529_bib24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMe058042","article-title":"COX-2 inhibitors\u2014lessons in drug safety","volume":"352","author":"Psaty","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.105.020529_bib25","first-page":"1923","article-title":"Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma","volume":"7","author":"Saukkonen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.105.020529_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1172\/JCI200319547","article-title":"Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing","volume":"112","author":"Sazani","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.020529_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0958-1669(02)00366-X","article-title":"Short-term and long-term modulation of gene expression by antisense therapeutics","volume":"13","author":"Sazani","year":"2002","journal-title":"Curr Opin Biotech"},{"key":"10.1124\/mol.105.020529_bib28","doi-asserted-by":"crossref","first-page":"21783","DOI":"10.1074\/jbc.274.31.21783","article-title":"Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake","volume":"274","author":"Schmajuk","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020529_bib29","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1073\/pnas.93.23.12840","article-title":"Repair of thalassemic human \u03b2-globin mRNA in mammalian cells by antisense oligonucleotides","volume":"93","author":"Sierakowska","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020529_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S135583829998130X","article-title":"Sensitivity of splice sites to antisense oligonucleotides in vivo","volume":"5","author":"Sierakowska","year":"1999","journal-title":"RNA"},{"key":"10.1124\/mol.105.020529_bib31","doi-asserted-by":"crossref","first-page":"11125","DOI":"10.1677\/jme.0.0220125","article-title":"Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy","volume":"22","author":"Slater","year":"1999","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/mol.105.020529_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9378(95)90087-X","article-title":"Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term","volume":"172","author":"Slater","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/mol.105.020529_bib33","first-page":"141","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochem Biophys Acta"},{"key":"10.1124\/mol.105.020529_bib34","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"key":"10.1124\/mol.105.020529_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1096\/fj.03-0645rev","article-title":"Cyclooxygenases: new forms, new inhibitors and lessons from the clinic","volume":"18","author":"Warner","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/mol.105.020529_bib36","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","article-title":"The role of cyclooxygenases in inflammation, cancer and development","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/mol.105.020529_bib37","first-page":"4997","article-title":"Expression of cyclooxygenase-2 in human lung carcinoma","volume":"58","author":"Wolff","year":"1998","journal-title":"Cancer Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24050971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24050971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.020529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:01:21Z","timestamp":1739966481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24050971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0026895X24050971"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.020529","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Targeting of Cyclooxygenase-2 (COX-2) Pre-mRNA Using Antisense Morpholino Oligonucleotides Directed to the 3\u2032 Acceptor and 5\u2032 Donor Splice Sites of Exon 4: Suppression of COX-2 Activity in Human Amnion-Derived WISH and Myometrial Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.020529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}